Shares dropped 4.1% as full-year outlook failed to impress. Revenue rose 5% to $12.8B, surpassing estimates. EPS lower than Wall Street's average, mid-single-digit growth expected for fiscal 2024. Inventory difficulties caused slight decrease in gross margin.
